Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Capital Employed (2021 - 2025)

Oncology Institute's Return on Capital Employed history spans 5 years, with the latest figure at 0.39% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 10.0% year-over-year to 0.39%; the TTM value through Dec 2025 reached 0.39%, up 10.0%, while the annual FY2025 figure was 0.37%, 6.0% up from the prior year.
  • Return on Capital Employed reached 0.39% in Q4 2025 per TOI's latest filing, up from 0.43% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.05% in Q2 2021 to a low of 0.49% in Q2 2022.
  • Average Return on Capital Employed over 5 years is 0.37%, with a median of 0.43% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: tumbled -45bps in 2022, then grew 10bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.25% in 2021, then plummeted by -38bps to 0.34% in 2022, then dropped by -28bps to 0.43% in 2023, then dropped by -13bps to 0.49% in 2024, then rose by 20bps to 0.39% in 2025.
  • Per Business Quant, the three most recent readings for TOI's Return on Capital Employed are 0.39% (Q4 2025), 0.43% (Q3 2025), and 0.48% (Q2 2025).